Successful cefiderocol therapy of severe infections due to difficult-to-treat Pseudomonas aeruginosa in two allogeneic hematopoietic stem cell transplantation recipients

Ann Hematol. 2022 Jun;101(6):1365-1367. doi: 10.1007/s00277-021-04737-z. Epub 2022 Jan 18.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Cefiderocol
  • Cephalosporins / therapeutic use
  • Drug Resistance, Multiple, Bacterial
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Pseudomonas Infections* / drug therapy
  • Pseudomonas aeruginosa

Substances

  • Anti-Bacterial Agents
  • Cephalosporins